摘要
目的探讨厄贝沙坦治疗房颤的临床疗效。方法选取我院在2011年1月至2014年1月收治的房颤患者60例,随机分为观察组和对照组,两组均给予胺碘酮治疗,观察组加用厄贝沙坦治疗,并比较两组左心房内径变化和窦性心律维持情况。结果观察组治疗后左心房内径为(36.5±3.7)mm,明显小于对照组(P<0.05);治疗12个月时共22例患者维持窦性心律,明显大于对照组(P<0.05)。结论厄贝沙坦在房颤治疗中作用效果显著,可明显改善患者左心房内径,维持正常心律。
Objective To investigate the clinical effect of irbesartan in the treatment of atrial fibrillation. Methods In our hospital in 2011 January to 2014 January 60 cases were patients with atrial fibrillation, were randomly dividedinto observation group and control group, two groups were treated withamiodarone treatment, the observation group were treated with irbesartan, and compared between the two groups of the change of left atrial diameterand sinus rhythm maintenance. Results The observation group after treatment,left atrial diameter was（36.5±3.7）mm,significantly less than the control group（P〈0.05）;treatment for 12 months, a total of 22 patients with sinus rhythm maintenance, significantly higher than the control group （P〈0.05）. Conclusion The effect of irbesartan in the treatment of AF effect significantly,can significantly improve the internal diameter of left atrium in patients withnormal heart rhythm.
出处
《中国卫生标准管理》
2014年第23期168-170,共3页
China Health Standard Management
关键词
房颤
厄贝沙坦
疗效
Atrial fibril ation,Irbesartan,Curative effect
